GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Healthcare Leaders Income ETF (TSX:HHL) » Definitions » Research & Development

Healthcare Leadersome ETF (TSX:HHL) Research & Development : C$0.00 Mil (TTM As of Jun. 2016)


View and export this data going back to 2014. Start your Free Trial

What is Healthcare Leadersome ETF Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Healthcare Leadersome ETF's Research & Development for the six months ended in Jun. 2016 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 was C$0.00 Mil.

Healthcare Leadersome ETF Research & Development Historical Data

The historical data trend for Healthcare Leadersome ETF's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare Leadersome ETF Research & Development Chart

Healthcare Leadersome ETF Annual Data
Trend Dec14 Dec15
Research & Development
- -

Healthcare Leadersome ETF Semi-Annual Data
Dec14 Jun15 Dec15 Jun16
Research & Development - - - -

Healthcare Leadersome ETF Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare Leadersome ETF  (TSX:HHL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthcare Leadersome ETF Research & Development Related Terms

Thank you for viewing the detailed overview of Healthcare Leadersome ETF's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthcare Leadersome ETF (TSX:HHL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Healthcare Leaders Income ETF (TSX:HHL) » Definitions » Research & Development
Comparable Companies
KUW:ALOLA IST:GSDHO TSX:SBC OSTO:DDM XKRX:214680 OSTO:NAXS BOM:511208 WAR:QRS TSE:8462 HKSE:00575 XTAE:MRIN XPAR:IRD XTER:B7E JSE:RACP OHEL:TITAN WAR:GKI ASX:VELCP SVVC XKRX:208350 TSX:DF
Traded in Other Exchanges
N/A
Address
Website
http://www.harvestportfolios.com
Healthcare Leaders Income ETF is a closed-end fund. Its investment objectives are to provide unit holders with the opportunity for capital appreciation; monthly cash distributions; and lower overall volatility of portfolio returns.

Healthcare Leadersome ETF (TSX:HHL) Headlines

No Headlines